American Society of Hirudotherapy

Pharmacy Board of Mauritius — Ministry of Health and Wellness

Mauritius Pharmacy Board · Mauritius · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Mauritius pharmacy regulator — leech-specific authorisation pathway not independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Mauritius
Leech status
unregulated
Last ASH review
2026-05-28

Relevant Regulation Codes

  • Mauritius Pharmacy Act 1983 and amendments
  • Mauritius Pharmacy (Health Standards) Regulations

Prescriber Requirements

  • Mauritius Medical Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Mauritius Pharmacy Board registration as applicable; English and French-language labelling. Standard cold-chain conditions.

Import/Export Rules

Mauritius Pharmacy Board and Mauritius Animal and Plant Health Division clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Mauritius public health system coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / traditional-medicine framework as appropriate.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.